Affordable Access

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.

Authors
Type
Published Article
Journal
Journal of Hypertension
0263-6352
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
20
Issue
10
Pages
2089–2093
Identifiers
PMID: 12359989
Source
Medline

Abstract

Statistics

Seen <100 times